Pharmafile Logo
Pharmafocus logo
Advanced Search

IMS Health

Showing 13 posts of 13 posts found.

cancer_cells

Global oncology market to reach $150 billion by 2020, says IMS Health

June 2, 2016
Research and Development IMS Health, annual global growth, cancer drugs, oncology

Global sales of oncology drugs rose to $107 billion in 2015, according to a new IMS Health report, with growth …

News
ims_health_quintiles

Quintiles to merge with IMS Health

May 3, 2016
Medical Communications, Research and Development, Sales and Marketing IMS Health, Quintiles, merger

IMS Health (NYSE: IMS) and Quintiles (NYSE: Q) have announced that a definitive merger agreement has been made between the …

News
shutterstock_211705468

US annual spending on drugs rose 12.2% in 2015 – IMS

April 15, 2016
Medical Communications, Research and Development, Sales and Marketing IMS Health, drug spending

The total US spending on prescription drugs rose 12.2% to almost $425 billion in 2015 on the back of new …

News
pills

Global drug spending will rise 30% by 2020, to $1.4 trillion

November 18, 2015
Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing

Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …

News
Keytruda image

Worldwide cancer spending tops $100 billion

May 5, 2015
Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology

Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …

News
tim_sheppard

IMS Health appoints general manager

March 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IMS Health, sheppard

Technology services firm IMS Health has named Tim Sheppard as the new general manager for its UK and Ireland business.  Sheppard …

Appointment
capture

HGS founders join IMS Health team

October 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane

Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team. 

Appointment
fda_building

Fitch to pharma: don’t expect 2012 to be a bumper year

July 31, 2012
Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings

The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News

AstraZeneca does data deal

January 13, 2012
Sales and Marketing AstraZeneca, IMS Health, data

AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …

News

Generics push US drug growth to $307bn

April 20, 2011
IMS, IMS Health, drug spending, healthcare spending

Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …

News

Pharma sector growth to improve in 2011

November 19, 2010
Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma

2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …

News

Pfizer extends portfolio with Brazilian generics deal

October 21, 2010
Brazil, IMS Health, Pfizer, em, emerging pharma marketings

Pfizer is partnering with leading Brazilian generics firm Laboratorio Teuto Brasileiro to develop and commercialise a number of generic products …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023